icon-folder.gif   Conference Reports for NATAP  
 
  The International Liver Congress™
EASL 2017 - European Association for the
Study of the Liver
Amsterdam, The Netherlands. 2017
Back grey_arrow_rt.gif
 
 
 
Comparison of Efficacy and Safety of Ombitasvir/Paritaprevir/Ritonavir and Dasabuvir ± Ribavirin Between Asian and Western HCV GT1b-infected Patients
 
 
  Reported by Jules Levin
EASL 2017 April 19-23 Amsterdam Netherlands
 
Lai Wei1, Yan Luo2, Wang-Long Chuang3, Seung Woon Paik4, Ming-Lung Yu5, Linda M Fredrick2, Andrew Campbell2, Roger Trinh2, Jeffrey Enejosa2, Nancy S Shulman2, Sarah Kopecky-Bromberg2, Jeong Heo6, Niloufar Mobashery2
 
1Peking University People's Hospital, Beijing, China; 2AbbVie Inc., North Chicago, Illinois, United States; 3Kaohsiung Medical University Hospital, Kaohsiung, Taiwan; 4Department of Medicine, Samsung Medical Center, Sungkyunkwan, Republic of Korea; 5Kaohsiung Medical University Hospital, Kaohsiung Medical University, Kaohsiung, Taiwan; 6Department of Internal Medicine, College of Medicine, Pusan Nati onal University and Medical Research Insti tute, Pusan Nati onal University Hospital, Busan, Republic of Korea

0509171

0509172

0509173

0509174

0509175

0509176